Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 758.15 BATS BZX Real-Time Price As of 1:18pm ET |  +10.30 / +1.38%Today’s Change | 538.01 Today|||52-Week Range 800.48 | +5.08% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 4.1B | 4.9B | 5.9B | 6.7B | |
| Cost of Goods Sold | 392.7M | 299.7M | 397.1M | 434.1M | ||
| Depreciation And Amortization | 74.9M | 104.7M | 145.5M | 148.2M | ||
| Operating Expenses | Gross Income | 3.6B | 4.5B | 5.3B | 6.1B | |
| General Expenses | 2.4B | 3.1B | 3.3B | 3.6B | ||
| Research And Development | 1.5B | 1.9B | 1.9B | 2.0B | ||
| Total Operating Expenses | 2.9B | 3.5B | 3.8B | 4.2B | ||
| Non-Operating Expenses | Operating Income | 1.3B | 1.3B | 2.1B | 2.5B | |
| Extraordinary Charge | -18.9M | -9.8M | -30.1M | -41.9M | ||
| Interest Expense On Debt | 14.2M | 7.2M | 25.1M | 28.2M | ||
| Other Expenses | 0.00 | 16.1M | 54.1M | 89.2M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 1.2B | 1.3B | 2.1B | 2.6B | |
| Income Taxes | -589.0M | -434.3M | -880.0M | -109.1M | ||
| Net Income | 636.1M | 895.5M | 1.2B | 2.4B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 103.1M | 104.7M | 106.3M | 107.9M | |
| Shares To Calculate EPS Diluted | 115.2M | 116.4M | 116.0M | 114.8M | ||
| Earnings Per Share | EPS | $5.52 | $7.70 | $10.34 | $21.29 | |
| EPS Diluted | $5.52 | $7.70 | $10.34 | $21.29 | ||
